MediWound (MDWD) Non-Current Deffered Revenue (2016 - 2022)
MediWound's (MDWD) quarterly Non-Current Deffered Revenue came in at $31000.0 in Q3 2022, down 91.19% year-on-year from $352000.0 in Q3 2021, and down 49.18% quarter-over-quarter from $61000.0 in Q2 2022.
MediWound (MDWD) Non-Current Deffered Revenue (2016 - 2022) Analysis & Trends
MediWound's Non-Current Deffered Revenue history runs 7 years deep, the most recent figure standing at $31000.0 for Q3 2022.
- On a quarterly basis, Non-Current Deffered Revenue fell 91.19% year-over-year to $31000.0 in Q3 2022; TTM through Sep 2022 was $31000.0, a 91.19% decrease from a year earlier, with the FY2021 full-year figure at $119000.0, down 90.36% from the prior year.
- Non-Current Deffered Revenue eased to $31000.0 in Q3 2022 per MDWD's latest filing, from $61000.0 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $1.3 million in Q1 2018 and bottomed at $31000.0 in Q3 2022.
- The 5-year median for Non-Current Deffered Revenue is $1.1 million (2019), against an average of $835421.1.
- Across the five-year window, Non-Current Deffered Revenue surged 35.58% in 2018 and plunged 91.19% in 2022, its largest moves.
- Year by year, Non-Current Deffered Revenue stood at $1.2 million in 2018, then decreased by 1.99% to $1.1 million in 2019, then climbed by 8.72% to $1.2 million in 2020, then slumped by 90.36% to $119000.0 in 2021, then plunged by 73.95% to $31000.0 in 2022.
- Per Business Quant, the three latest MDWD Non-Current Deffered Revenue figures stand at $31000.0 (Q3 2022), $61000.0 (Q2 2022), and $91000.0 (Q1 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 225.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | MediWound | 183.16 Mn | 178.36 Mn | 278,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 31,000.00 |
| Jun 30, 2022 | 61,000.00 |
| Mar 31, 2022 | 91,000.00 |
| Dec 31, 2021 | 119,000.00 |
| Sep 30, 2021 | 352,000.00 |
| Jun 30, 2021 | 405,000.00 |
| Mar 31, 2021 | 693,000.00 |
| Dec 31, 2020 | 1.23 Mn |
| Sep 30, 2020 | 1.28 Mn |
| Jun 30, 2020 | 1.17 Mn |
| Mar 31, 2020 | 1.02 Mn |
| Dec 31, 2019 | 1.14 Mn |
| Sep 30, 2019 | 1.13 Mn |
| Jun 30, 2019 | 1.14 Mn |
| Mar 31, 2019 | 1.15 Mn |
| Dec 31, 2018 | 1.16 Mn |
| Sep 30, 2018 | 1.17 Mn |
| Jun 30, 2018 | 1.18 Mn |
| Mar 31, 2018 | 1.35 Mn |
| Dec 31, 2017 | 988,000.00 |